Sunbelt Securities’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-100,296
Closed -$69K 455
2020
Q4
$69K Buy
+100,296
New +$214K 0.01% 387

Other funds holding BMY.RT

Sunbelt Securities's BMY.RT Position: Q1 2021 in Review

Sunbelt Securities sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 100,296 shares — an estimated $69K sold.

Sunbelt Securities first reported a position in BMY.RT in Q4 2020 and held it in 1 quarter. The position peaked at $69K in Q4 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Sunbelt Securities reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Sunbelt Securities sold 100,296 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $69K.
  • Sunbelt Securities first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2020 and held it in 1 quarter.
  • Sunbelt Securities's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $69K in Q4 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Sunbelt Securities's 13F filing for Q1 2021, filed 27 May 2021.